Data as of Mar 07
| -4.48 / -6.84%|
The 13 analysts offering 12-month price forecasts for Imperva Inc have a median target of 60.00, with a high estimate of 75.00 and a low estimate of 50.00. The median estimate represents a -1.72% decrease from the last price of 61.05.
The current consensus among 15 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.